Samalin Investment Counsel, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1544366 CHAPPAQUA, NY

Position in REGN

as of Mar 31, 2026 · filed Apr 23, 2026 Compact

Position Value

$394,819

-$7,325 QoQ

Shares Held

511

-1.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

20 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Samalin Investment Counsel, LLC holds $218,633 across 2 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)	Open
1	NKTX	Nkarta, Inc.	40,750	$115,322
2	KYTX	Kyverna Therapeutics, Inc.	11,595	$103,311

20 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$394,819	511	-1.9%	Shares	Sole	2026-04-23
2025-12-31	$402,144	521	-2.8%	Shares	Sole	2026-01-30
2025-09-30	$301,376	536	+2.5%	Shares	Sole	2025-10-30
2025-06-30	$274,575	523	-40.1%	Shares	Sole	2025-08-07
2025-03-31	$553,682	873	+15.5%	Shares	Sole	2025-05-14
2024-12-31	$538,521	756	-4.4%	Shares	Sole	2025-02-11
2024-09-30	$831,530	791	+15.0%	Shares	Sole	2024-11-13
2024-06-30	$723,108	688	+0.7%	Shares	Sole	2024-08-13
2024-03-31	$657,380	683	-3.1%	Shares	Sole	2024-05-13
2023-12-31	$619,194	705	-0.7%	Shares	Sole	2024-02-14
2023-09-30	$584,301	710	-1.1%	Shares	Sole	2023-11-13
2023-06-30	$515,911	718	-5.3%	Shares	Sole	2023-08-03
2023-03-31	$622,825	758	-0.5%	Shares	Sole	2023-05-09
2022-12-31	$549,775	762	-6.5%	Shares	Sole	2023-02-10
2022-09-30	$561,429	815	+5.6%	Shares	Sole	2022-11-10
2022-06-30	$456,352	772	-19.5%	Shares	Sole	2022-08-15
2022-03-31	$669,784	959	0.0%	Shares	Sole	2022-10-14
2021-12-31	$605,627	959	0.0%	Shares	Sole	2022-10-14
2021-09-30	$580,367	959	+4.8%	Shares	Sole	2022-10-14
2021-06-30	$511,064	915	—	Shares	Sole	2022-10-14
No filing history on record for this holder in this stock.